Bariatric Surgery Associated With Remission of Prediabetes and Type 2 Diabetes
Investigators assessed outcomes 5 years after bariatric surgery among patients with obesity and type 2 diabetes.
Bariatric Surgery
Roux-en-Y Gastric Bypass May Increase Risk for De Novo Alcohol-Related Outcomes
Investigators assessed the associations between bariatric surgery and de novo alcohol-related outcomes.
Increased Testosterone Reported in Male Adolescents Following Bariatric Surgery for Severe Obesity
A team of researchers investigated the effect of bariatric surgery on testosterone levels in adolescents with severe obesity.
Better COVID-19 Outcomes Observed In People Following Weight Loss Surgery
Obesity and its related complications are a risk factor for adverse outcomes in people who contract COVID-19 infection. Investigators studied whether losing weight improved outcomes in people who lost weight after weight reduction surgery.
Few Adolescents With Severe Obesity Choose Bariatric Surgery, Despite Demonstrated Benefits
Investigators compared outcomes between adolescents with obesity that did and did not proceed to metabolic and bariatric surgery after referral.
Novel Endoscopic Resection Suturing Technique for the Treatment of Obesity
Investigators tested the safety and efficacy of the osculating circles gastroplasty technique for use during bariatric surgeries.
Bariatric Surgery Cuts Hepatic Steatosis in Obesity and T2DM
Sleeve gastrectomy and RYGB are highly effective for reducing hepatic steatosis in patients with severe obesity and type 2 diabetes, with almost complete clearance of liver fat one year after surgery.
Predicting Type 2 Diabetes Remission Following Bariatric Surgery
Among models and validation studies reviewed, the ABCD and DiaRem models most accurately predicted type 2 diabetes remission after bariatric surgery.
No Difference in Health Care Expenditures Between RYGB and Sleeve Gastrectomy Procedures
Investigators compared 4-year health care expenditures between Roux-en-Y gastric bypass and sleeve gastrectomy.
Bariatric Surgery May Cut Risk for Adverse Outcomes in NASH
Among patients with nonalcoholic steatohepatitis (NASH) and obesity, bariatric surgery is associated with a significantly lower risk for adverse liver and cardiovascular outcomes.
- Loading...
Loading...
Next post in Obesity
Loading... 
Loading...